⌘K
Loading ticker…
As of 2026-08-24, Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) has a 3-month relative strength percentile of 13 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 31. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 14.3%, relative volume 2.05×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
SCNI appears in 1 ETF as of Mar 2026: SPDW at 0.00% weight, $1 notional.
Held by 1 ETFs · $1 across latest filings · largest weight 0.00% (SPDW).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SPDWState Street SPDR Portfolio Developed World ex-US ETF | 0.00% | $1 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SCNI Jan avg: 7.98% median: 7.29% win: 67% σ: 29.30% n: 3 2023-09-08 → 2026-07-31 | SCNI Feb avg: -2.12% median: -1.36% win: 33% σ: 6.86% n: 3 2023-09-08 → 2026-07-31 | SCNI Mar avg: -18.01% median: -23.90% win: 33% σ: 21.41% n: 3 2023-09-08 → 2026-07-31 | SCNI Apr avg: 5.15% median: -2.06% win: 33% σ: 21.97% n: 3 2023-09-08 → 2026-07-31 | SCNI May avg: -17.90% median: -17.60% win: 33% σ: 21.14% n: 3 2023-09-08 → 2026-07-31 | SCNI Jun avg: -28.64% median: -25.86% win: 0% σ: 14.05% n: 3 2023-09-08 → 2026-07-31 | SCNI Jul avg: 13.25% median: 8.08% win: 67% σ: 51.99% n: 3 2023-09-08 → 2026-07-31 | SCNI Aug avg: -7.58% median: -7.58% win: 50% σ: 17.50% n: 2 2023-09-08 → 2026-07-31 (current) | SCNI Sep avg: -19.80% median: -17.32% win: 0% σ: 13.70% n: 3 2023-09-08 → 2026-07-31 | SCNI Oct avg: -3.43% median: 3.19% win: 67% σ: 18.32% n: 3 2023-09-08 → 2026-07-31 | SCNI Nov avg: -6.95% median: -3.37% win: 33% σ: 17.95% n: 3 2023-09-08 → 2026-07-31 | SCNI Dec avg: -16.94% median: -17.19% win: 0% σ: 14.05% n: 3 2023-09-08 → 2026-07-31 |